Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 525

Results For "GE"

7638 News Found

Bulk Drug Park in the country :PIB
Policy | July 27, 2022

Bulk Drug Park in the country :PIB

The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park


Pharmaceuticals industry under Atmanirbhar Bharat programme
Policy | July 27, 2022

Pharmaceuticals industry under Atmanirbhar Bharat programme

India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.


Tealium launches customer data platform for pharma
Digitisation | July 27, 2022

Tealium launches customer data platform for pharma

Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors


Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
Clinical Trials | July 27, 2022

Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study

The NTM-001 Phase I clinical study is expected to be completed by the end of 2022


SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData
News | July 27, 2022

SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData

This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines


AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy
News | July 27, 2022

AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy

AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.


Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
Drug Approval | July 26, 2022

Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets

The product will be manufactured at Lupin's facility in Nagpur, India.


Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
News | July 26, 2022

Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.


Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets
Digitisation | July 26, 2022

Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets

The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.